The impact of antiplatelet drugs on short-term bleeding risk after colorectal polypectomy at different recovery times (day after surgery vs. elective surgery): a prospective, multicenter, randomized controlled study

INTERVENTION: experimental group:Antiplatelet therapy resumed the following day.;control group:Antiplatelet therapy will be scheduled for the next day.; CONDITION: Colorectal polyps PRIMARY OUTCOME: Impact of postoperative bleeding risk; SECONDARY OUTCOME: All‐cause mortality rate;Readmission rate, readmission rate (endoscopy/intervention/surgery);Cardiovascular and cerebrovascular events 30 days after surgery; INCLUSION CRITERIA: 1. Age >= 18 years, scheduled for elective colorectal polyp resection. 2. Long‐term antiplatelet therapy (aspirin or P2Y12 inhibitor monotherapy). 3. Polyps assessed as suitable for complete endoscopic resection. 4. Stable clinical condition, able to tolerate endoscopic procedures. 5. Signed informed consent form, agreeing to participate in this study and accept follow‐up.